{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:48:32Z","timestamp":1770493712451,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This study has not beneficed of any financial support."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Rapid diagnostic tests are tools of paramount impact both for improving patient care and in antimicrobial management programs. Particularly in the case of respiratory infections, it is of great importance to quickly confirm\/exclude the involvement of pathogens, be they bacteria or viruses, while obtaining information about the presence\/absence of a genetic target of resistance to modulate antibiotic therapy. In this paper, we present our experiences with the use of the Biofire\u00ae FilmArray\u00ae Pneumonia Panel Plus (FAPP; bioM\u00e9rieux; Marcy l\u2019Etoile, France) to assess coinfection in COVID-19 patients. A total of 152 respiratory samples from consecutive patients were examined, and 93 (61%) were found to be FAPP positive, with the detection of bacteria and\/or viruses. The patients were 93 males and 59 females with an average age of 65\u00a0years who were admitted to our hospital due to moderate\/severe acute respiratory symptoms. Among the positive samples were 52 from sputum (SPU) and 41 from bronchoalveolar lavage (BAL). The most representative species was <jats:italic>S. aureus<\/jats:italic> (most isolates were <jats:italic>mec<\/jats:italic>A positive; 30\/44, 62%), followed by gram-negative pathogens such as <jats:italic>P. aeruginosa<\/jats:italic>, <jats:italic>K. pneumoniae<\/jats:italic>, and <jats:italic>A. baumannii<\/jats:italic>. Evidence of a virus was rare. Cultures performed from BAL and SPU samples gave poor results. Most of the discrepant negative cultures were those in which FAPP detected pathogens with a microbial count\u2009\u2264\u200910<jats:sup>5<\/jats:sup>\u00a0CFU\/mL. <jats:italic>H. influenzae<\/jats:italic> was one of the most common pathogens lost by the conventional method. Despite the potential limitations of FAPP, which detects a defined number of pathogens, its advantages of rapid detection combined with predictive information regarding the antimicrobial resistance of pathogens through the detection of some relevant markers of resistance could be very useful for establishing empirical targeted therapy for the treatment of patients with respiratory failure. In the COVID era, we understand the importance of using antibiotics wisely to curb the phenomenon of antibiotic resistance.<\/jats:p>","DOI":"10.1038\/s41598-021-95772-3","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T10:09:03Z","timestamp":1628676543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Co-infections observed in SARS-CoV-2 positive patients using a rapid diagnostic test"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2198-1947","authenticated-orcid":false,"given":"Carla","family":"Fontana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3502-8332","authenticated-orcid":false,"given":"Marco","family":"Favaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Minelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"Bossa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"key":"95772_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5 (2020).","journal-title":"Lancet"},{"key":"95772_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2020.100682","volume":"19","author":"RA Khailany","year":"2020","unstructured":"Khailany, R. A., Safdar, M. & Ozaslan, M. Genomic characterization of a novel SARS-CoV-2. Gene Rep. 19, 100682. https:\/\/doi.org\/10.1016\/j.genrep.2020.100682 (2020).","journal-title":"Gene Rep."},{"issue":"5","key":"95772_CR3","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/cid\/ciz803","volume":"70","author":"AS Monto","year":"2020","unstructured":"Monto, A. S. & Fukuda, K. Lessons from influenza pandemics of the last 100 years. Clin. Infect. Dis. 70(5), 951\u2013957. https:\/\/doi.org\/10.1093\/cid\/ciz803 (2020).","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"95772_CR4","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.21276\/SSR-IIJLS.2020.6.2.5","volume":"6","author":"K Rao","year":"2020","unstructured":"Rao, K. et al. Review on Newly identified coronavirus and its genomic organization. SSR Inst. Int. J. Life Sci. 6(2), 2509\u20132519 (2020).","journal-title":"SSR Inst. Int. J. Life Sci."},{"key":"95772_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00461-z","author":"O Vandenberg","year":"2020","unstructured":"Vandenberg, O., Martiny, D., Rochas, O., van Belkum, A. & Kozlakidis, Z. Considerations for diagnostic COVID-19 tests. Nat. Rev. Microbiol. https:\/\/doi.org\/10.1038\/s41579-020-00461-z (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"95772_CR6","doi-asserted-by":"publisher","unstructured":"Bordi, L., Nicastri, E., Scorzolini, L., Di Caro, A., Capobianchi, M.R., Castilletti, C., Lalle, E., On Behalf of Inmi Covid-Study Group and Collaborating Centers. Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020. Euro Surveill. 25(8) 2000170. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.8.2000170. (2020).","DOI":"10.2807\/1560-7917.ES.2020.25.8.2000170"},{"key":"95772_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(20)30009-48","author":"MJ Cox","year":"2020","unstructured":"Cox, M. J., Loman, N., Bogaert, D. & O\u2019Grady, J. Co-infections: Potentially lethal and unexplored in COVID-19. Lancet Microbe. https:\/\/doi.org\/10.1016\/S2666-5247(20)30009-48 (2020).","journal-title":"Lancet Microbe."},{"issue":"11","key":"95772_CR8","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1002\/jmv.26073","volume":"92","author":"Z Li","year":"2020","unstructured":"Li, Z. et al. Coinfection with SARS-CoV-2 and other respiratory pathogens in patients with COVID-19 in Guangzhou, China. J. Med. Virol. 92(11), 2381\u20132383. https:\/\/doi.org\/10.1002\/jmv.26073 (2020) (Epub 2020 Jul 27. PMID: 32462695; PMCID: PMC7283743).","journal-title":"J. Med. Virol."},{"issue":"5","key":"95772_CR9","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","volume":"46","author":"Q Ruan","year":"2020","unstructured":"Ruan, Q., Yang, K., Wang, W., Jiang, L. & Song, J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 46(5), 846\u2013848. https:\/\/doi.org\/10.1007\/s00134-020-05991-x (2020) (Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Apr 6; PMID: 32125452; PMCID: PMC7080116.10).","journal-title":"Intensive Care Med."},{"issue":"2","key":"95772_CR10","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","volume":"81","author":"L Lansbury","year":"2020","unstructured":"Lansbury, L., Lim, B., Baskaran, V. & Lim, W. S. Co-infections in people with COVID-19: A systematic review and meta-analysis. J. Infect. 81(2), 266\u2013275. https:\/\/doi.org\/10.1016\/j.jinf.2020.05.046 (2020).","journal-title":"J. Infect."},{"issue":"7","key":"95772_CR11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1513\/AnnalsATS.202003-225OC","volume":"17","author":"RH Du","year":"2020","unstructured":"Du, R. H. et al. Hospitalization and critical care of 109 decedents with COVID-19 pneumonia in Wuhan, China. Ann. Am. Thorac. Soc. 17(7), 839\u2013846. https:\/\/doi.org\/10.1513\/AnnalsATS.202003-225OC (2020) (PMID: 32255382; PMCID: PMC7328178).","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"15","key":"95772_CR12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/cid\/ciaa272","volume":"71","author":"Z Wang","year":"2020","unstructured":"Wang, Z., Yang, B., Li, Q., Wen, L. & Zhang, R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin. Infect. Dis. 71(15), 769\u2013777. https:\/\/doi.org\/10.1093\/cid\/ciaa272 (2020).","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"95772_CR13","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu, C. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. 180(7), 934\u2013943. https:\/\/doi.org\/10.1001\/jamainternmed.2020.0994 (2020).","journal-title":"JAMA Intern. Med."},{"key":"95772_CR14","unstructured":"NICE. Managing suspected or confirmed pneumonia | COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community | Guidance | NICE. 2020.https:\/\/www.nice.org.uk\/guidance\/ng165\/chapter\/4-Managing-suspected368 or-confirmed-pneumonia (Accessed 20 July 2020)."},{"key":"95772_CR15","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3389\/FMICB.2017.01041","volume":"8","author":"DE Morris","year":"2017","unstructured":"Morris, D. E., Cleary, D. W. & Clarke, S. C. Secondary bacterial infections associated with influenza pandemics. Front. Microbiol. 8, 1041. https:\/\/doi.org\/10.3389\/FMICB.2017.01041 (2017).","journal-title":"Front. Microbiol."},{"issue":"5","key":"95772_CR16","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1097\/CCM.0b013e3182416f23","volume":"40","author":"TW Rice","year":"2012","unstructured":"Rice, T. W. et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit. Care Med. 40(5), 1487\u20131498. https:\/\/doi.org\/10.1097\/CCM.0b013e3182416f23 (2012) (PMID: 22511131; PMCID: PMC3653183).","journal-title":"Crit. Care Med."},{"issue":"7","key":"95772_CR17","doi-asserted-by":"publisher","first-page":"e02068","DOI":"10.1128\/mBio.02068-16","volume":"2016","author":"ME Mulcahy","year":"2016","unstructured":"Mulcahy, M. E. & McLoughlin, R. M. Staphylococcus aureus and influenza A virus: Partners in co-infection. MBio 2016(7), e02068-e2116. https:\/\/doi.org\/10.1128\/mBio.02068-16 (2016).","journal-title":"MBio"},{"key":"95772_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinpr.2020.100026","author":"B Canning","year":"2020","unstructured":"Canning, B., Senanayake, R. V., Burns, D., Moran, E. & Dedicoat, M. Post-influenza Aspergillus ventriculitis. Clin. Infect. Pract. https:\/\/doi.org\/10.1016\/j.clinpr.2020.100026 (2020).","journal-title":"Clin. Infect. Pract."},{"issue":"10","key":"95772_CR19","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.cmi.2020.06.025","volume":"26","author":"S Hughes","year":"2020","unstructured":"Hughes, S., Troise, O., Donaldson, H., Mughal, N. & Moore, L. S. P. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin. Microbiol. Infect. 26(10), 1395\u20131399. https:\/\/doi.org\/10.1016\/j.cmi.2020.06.025 (2020).","journal-title":"Clin. Microbiol. Infect."},{"issue":"10","key":"95772_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13319","volume":"50","author":"DR Giacobbe","year":"2020","unstructured":"Giacobbe, D. R. et al. Bloodstream infections in critically ill patients with COVID-19. Eur. J. Clin. Invest. 50(10), e13319. https:\/\/doi.org\/10.1111\/eci.13319 (2020).","journal-title":"Eur. J. Clin. Invest."},{"key":"95772_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.08.012","author":"A Calcagno","year":"2021","unstructured":"Calcagno, A. et al. Co-infection with other respiratory pathogens in COVID-19 patients (2029). Clin. Microbiol. Infect. https:\/\/doi.org\/10.1016\/j.cmi.2020.08.012 (2021).","journal-title":"Clin. Microbiol. Infect."},{"issue":"9","key":"95772_CR22","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/cid\/ciaa530","volume":"71","author":"TM Rawson","year":"2020","unstructured":"Rawson, T. M. et al. Bacterial and fungal coinfection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin. Infect. Dis. 71(9), 2459\u20132468. https:\/\/doi.org\/10.1093\/cid\/ciaa530 (2020) (PMID: 32358954; PMCID: PMC7197596).","journal-title":"Clin. Infect. Dis."},{"key":"95772_CR23","volume-title":"Clinical Microbiology Procedures Handbook","author":"PH Gilligan","year":"2016","unstructured":"Gilligan, P. H., Alby, K. & York, M. K. Lower Respiratory Tract Cultures: Aerobic Bacteriology. Section 3.11.2.1\u20133.11.2.14. In Clinical Microbiology Procedures Handbook 4th edn (ed. Leber, A. L.) (ASM Press, 2016).","edition":"4"},{"issue":"3","key":"95772_CR24","doi-asserted-by":"publisher","first-page":"504","DOI":"10.4236\/aim.2013.36067","volume":"2013","author":"C Fontana","year":"2013","unstructured":"Fontana, C., Favaro, M. & Favalli, C. How liquid based microbiology can change the workflow in the microbiology laboratories. Adv. Microbiol. 2013(3), 504\u2013510. https:\/\/doi.org\/10.4236\/aim.2013.36067 (2013).","journal-title":"Adv. Microbiol."},{"key":"95772_CR25","unstructured":"EUCAST. Breakpoint tables for interpretation of MICs and zone diameters. Version 10.0. 2020. http:\/\/www.eucast.org\/clinical_breakpoints\/. (Accessed 1 Jan 2020)."},{"issue":"6","key":"95772_CR26","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jmii.2019.10.009","volume":"52","author":"SH Lee","year":"2019","unstructured":"Lee, S. H. et al. Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units. J. Microbiol. Immunol. Infect. 52(6), 920\u2013928. https:\/\/doi.org\/10.1016\/j.jmii.2019.10.009 (2019).","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"7","key":"95772_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/23744235.2020.1755053","volume":"52","author":"A Edin","year":"2020","unstructured":"Edin, A., Eilers, H. & Allard, A. Evaluation of the Biofire Filmarray Pneumonia panel plus for lower respiratory tract infections. Infect. Dis. 52(7), 479\u2013488. https:\/\/doi.org\/10.1080\/23744235.2020.1755053 (2020).","journal-title":"Infect. Dis."},{"issue":"7","key":"95772_CR28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2471\/BLT.20.268573","volume":"98","author":"H Getahun","year":"2020","unstructured":"Getahun, H., Smith, I., Trivedi, K., Paulin, S. & Balkhy, H. H. Tackling antimicrobial resistance in the COVID-19 pandemic. Bull. World Health Organ. 98(7), 442-442A. https:\/\/doi.org\/10.2471\/BLT.20.268573 (2020) (PMID: 32742026; PMCID: PMC7375214).","journal-title":"Bull. World Health Organ."},{"issue":"1","key":"95772_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13613-020-00736-x","volume":"10","author":"D Contou","year":"2020","unstructured":"Contou, D. et al. (2020) Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann. Intensive Care 10(1), 119. https:\/\/doi.org\/10.1186\/s13613-020-00736-x (2020) (PMID: 32894364; PMCID: PMC7475952).","journal-title":"Ann. Intensive Care"},{"issue":"5","key":"95772_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/MCC.0000000000000435","volume":"23","author":"K Cawcutt","year":"2017","unstructured":"Cawcutt, K. & Kalil, A. C. Pneumonia with bacterial and viral coinfection. Curr. Opin. Crit. Care 23(5), 385\u2013390. https:\/\/doi.org\/10.1097\/MCC.0000000000000435 (2017).","journal-title":"Curr. Opin. Crit. Care"},{"issue":"2","key":"95772_CR31","doi-asserted-by":"publisher","first-page":"e01658","DOI":"10.1128\/JCM.01658-17","volume":"56","author":"NE Babady","year":"2018","unstructured":"Babady, N. E. et al. Multicenter evaluation of the ePlex respiratory pathogen panel for the detection of viral and bacterial respiratory tract pathogens in nasopharyngeal swabs. J. Clin. Microbiol. 56(2), e01658-e1717 (2018).","journal-title":"J. Clin. Microbiol."},{"issue":"4","key":"95772_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jmii.2020.05.013","volume":"53","author":"CC Lai","year":"2020","unstructured":"Lai, C. C., Wang, C. Y. & Hsueh, P. R. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?. J. Microbiol. Immunol. Infect. 53(4), 505\u2013512. https:\/\/doi.org\/10.1016\/j.jmii.2020.05.013 (2020) (Epub 2020 May 23. PMID: 32482366; PMCID: PMC7245213).","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"2","key":"95772_CR33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jmii.2018.05.007","volume":"52","author":"IC Su","year":"2019","unstructured":"Su, I. C. et al. Severe community-acquired pneumonia due to Pseudomonas aeruginosa coinfection in an influenza A(H1N1)pdm09 patient. J. Microbiol. Immunol. Infect. 52(2), 365\u2013366. https:\/\/doi.org\/10.1016\/j.jmii.2018.05.007 (2019).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"95772_CR34","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jgar.2020.10.004","volume":"23","author":"MA Cataldo","year":"2020","unstructured":"Cataldo, M. A. et al. Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming \u201ccollateral effect\u201d. J. Glob. Antimicrob. Resist. 23, 290\u2013291. https:\/\/doi.org\/10.1016\/j.jgar.2020.10.004 (2020).","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"95772_CR35","unstructured":"ECDC: Antimicrobial resistance in the EU\/EEA (EARS-Net)- Annual Epidemiological Reports for 2019. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-antimicrobial-resistance-europe-2019. (Accessed 6 July 2021)."},{"issue":"4","key":"95772_CR36","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3201\/eid2704.204036","volume":"27","author":"A Patel","year":"2021","unstructured":"Patel, A. et al. Rapid spread and control of multidrug-resistant gram-negative bacteria in COVID-19 patient care units. Emerg. Infect. Dis. 27(4), 1234\u20131237. https:\/\/doi.org\/10.3201\/eid2704.204036 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"95772_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fnano.2020.571284","volume":"2","author":"P Paliwal","year":"2020","unstructured":"Paliwal, P. et al. Grand challenges in bio-nanotechnology to manage the COVID-19 pandemic. Front. Nanotechnol. 2, 571284. https:\/\/doi.org\/10.3389\/fnano.2020.571284 (2020).","journal-title":"Front. Nanotechnol."},{"key":"95772_CR38","doi-asserted-by":"crossref","unstructured":"Mujawar, M. A., Gohel, H., Bhardwaj, S. K., Srinivasan, S., Hickman, N., & Kaushik, A. Nano-enabled biosensing systems for intelligent healthcare: towards COVID-19 management. Mater. Today Chem. 17, 100306, ISSN 2468\u20135194. (2020).","DOI":"10.1016\/j.mtchem.2020.100306"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95772-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95772-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95772-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T12:30:56Z","timestamp":1670070656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95772-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["95772"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-95772-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,11]]},"assertion":[{"value":"25 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Carla Fontana has received a research grant by Angelini. Advisory Board: Angelini, Pfizer. Marco Favaro has received a research grant by Alifax R&D and Adaltis s.r.l. In no way the above declared competing interests have influenced the results reported in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16355"}}